Agilent Technologies Inc. (NYSE: A) today announced that Pascal Soriot, CEO of AstraZeneca, and Judy Gawlik Brown, founder ...

What Happened: Soriot made a significant move by purchasing 1,677 shares of Agilent Technologies as reported in a Form 4 filing with the U.S. Securities and Exchange Commission. The transaction's ...

AstraZeneca Chief Executive Officer Pascal Soriot said on Wednesday that just like Europe has stepped up its defence spending ...

AstraZeneca’s CEO Pascal Soriot has described 2017 as a “defining” year for the company, with a series of new products gaining traction and the worst of a series of patent losses in the past.

AstraZeneca (AZN) CEO Pascal Soriot is not overly concerned about the threat of tariffs by the Trump administration on pharmaceuticals and said a more favorable corporate tax credit could motivate ...

Harvey Jones says investment brokers showed their love for AstraZeneca shares at the start of the year, but maybe wondering ...

0856 ET – AstraZeneca’s Chief Executive officer Pascal Soriot says Europe must boost investment into healthcare, as it has done with defense spending, amid what he calls a shifting world order.

Pascal Soriot has led AstraZeneca as CEO since 2012, guiding the company’s transformation into a global leader in science-driven innovation with a strong pipeline and substantial growth.